Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


BrightFocus Foundation


Address

22512 Gateway Center Drive
Clarksburg, MD 20871 USA

Phone

301-556-9348

800 Number

800-437-2423

Email Address

info@brightfocus.org

Description

BrightFocus Foundation is a registered 501(c)(3) non-profit organization that drives innovative research worldwide and promotes awareness of Alzheimer’s, macular degeneration, and glaucoma. They disseminate vital information to the public through their website, print publications, social media, as well as TV and radio public service announcements (PSAs). Through their toll-free phone number, 1-800-437-2423, people can speak directly with a member of their information services staff, Monday through Friday from 9am to 5pm Eastern time, for answers to questions, support, and referrals.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.